UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

P16 Generalized Prevalence-Adjusted Willingness-to-Pay to Control for Health Equity in Cost-Effectiveness Analysis

Value in health, 2024-06, Vol.27 (6), p.S4-S4

2024

Volltextzugriff (PDF)

Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.: a cost-effectiveness analysis

Value in health, 2015-05, Vol.18 (3), p.A205-A205

2015

Volltextzugriff (PDF)

Are evidence-based practices associated with effective prevention of hospital-acquired pressure ulcers in u.s. Hospitals?

Value in health, 2015-05, Vol.18 (3), p.A275-A275

2015

Volltextzugriff (PDF)

HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US

Value in health, 2023-12, Vol.26 (12), p.S304

2023

Volltextzugriff (PDF)

Determining the cost of obesity and its common comorbidities from a commercial claims database

Clinical obesity, 2014-02, Vol.4 (1), p.53-58

2014

Volltextzugriff (PDF)

EE35 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Vs. Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Non-Squamous, Advanced Non-Small Cell Lung Cancer in the USA

Value in health, 2022-07, Vol.25 (7), p.S342

2022

Volltextzugriff (PDF)

P18 Assessing the Value of Revascularization Strategies for Chronic Limb Threatening Ischemia in Patients with Diabetic Foot Ulcers: A Propensity Score-Weighted Evaluation

Value in health, 2024-06, Vol.27 (6), p.S4-S5

2024

Volltextzugriff (PDF)

HPR4 $20.9 Billion Annually Wasted on “Defects in Value” for Total Knee and Hip Replacements in the United States

Value in health, 2023-06, Vol.26 (6), p.S211-S211

2023

Volltextzugriff (PDF)

HSD90 Value as the Next Innovation in Rectal Cancer Surgery: A Review

Value in health, 2023-06, Vol.26 (6), p.S254-S254

2023

Volltextzugriff (PDF)

EE419 Cost-Effectiveness Analysis of Non-Invasive Screening in Patients with Diabetic Foot Ulcers

Value in health, 2022-07, Vol.25 (7), p.S417

2022

Volltextzugriff (PDF)

EE395 Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis in Preterm Infants 29-35 Weeks' Gestation

Value in health, 2022-07, Vol.25 (7), p.S412

2022

Volltextzugriff (PDF)

EE288 A Cost-Effectiveness Analysis of Biologic Compared with Chemical Disease Modifying Drugs in Treating Multiple Sclerosis in US

Value in health, 2022-07, Vol.25 (7), p.S390

2022

Volltextzugriff (PDF)

EE245 Cost-Effectiveness of Therapeutic Hypothermia for Neonates with Mild Hypoxic-Ischemic Encephalopathy

Value in health, 2022-07, Vol.25 (7), p.S382

2022

Volltextzugriff (PDF)

PIH10 A Cost-Effectiveness Analysis of Repositioning Intervals for Pressure Injury Prevention: An Economic Evaluation of the "TEAM-up” Clinical Trial

Value in health, 2020-12, Vol.23, p.S540-S540

2020

Volltextzugriff (PDF)

EE209 Value Defects in Spine Surgery: How to Reduce Wasteful Care and Improve Value

Value in health, 2023-06, Vol.26 (6), p.S97-S97

2023

Volltextzugriff (PDF)

EE342 Compression Therapy with Early Endovenous Ablation in Venous Leg Ulceration in the U.S.: A Cost-Effectiveness Analysis

Value in health, 2022-07, Vol.25 (7), p.S402

2022

Volltextzugriff (PDF)

PIH16 ESTIMATING THE VALUE OF NURSING TIME TO REDUCE COSTS AND INCREASE QUALITY OF PRESSURE INJURY PREVENTION IN NURSING HOMES: A COST-EFFECTIVENESS ANALYSIS OF THE TEAM-UP CLINICAL TRIAL

Value in health, 2020-05, Vol.23, p.S154-S154

2020

Volltextzugriff (PDF)

EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective

Value in health, 2022-07, Vol.25 (7), p.S361

2022

Volltextzugriff (PDF)

EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States

Value in health, 2024-06, Vol.27 (6), p.S131-S131

2024

Volltextzugriff (PDF)

PIN21 The Cost-Utility of Remote Pulse-Oximeter Monitoring of COVID19 Patients

Value in health, 2021-06, Vol.24, p.S109-S109

2021

Volltextzugriff (PDF)

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis

Value in health, 2020-12, Vol.23, p.S568-S568

2020

Volltextzugriff (PDF)

PMU39 COOKING AT HOME CAN SAVE MONEY, REGARDLESS OF FOOD PRICE: A MULTILEVEL ANALYSIS OF MEALS PREPARED AWAY FROM THE HOME ON DIET MEASURES AND FOOD EXPENDITURES

Value in health, 2020-05, Vol.23, p.S240-S240

2020

Volltextzugriff (PDF)

PMU58 SMART SPENDING: REALLOCATING AMERICANSâ€™ FOOD BUDGETS TO SAVE COSTS AND IMPROVE DIET QUALITY

Value in health, 2020-05, Vol.23, p.S243-S244

2020

Volltextzugriff (PDF)

PCN67 USING INFORMATION FROM THE MICROBIOME TO IMPROVE THE EFFICIENCY OF SELECTING THERAPEUTIC OPTIONS FOR MELANOMA: A COST-EFFECTIVENESS ANALYSIS

Value in health, 2020-05, Vol.23, p.S35-S35

2020

Volltextzugriff (PDF)

What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?

Value in health, 2014-11, Vol.17 (7), p.A636-A636

2014

Volltextzugriff (PDF)

1 – 25 von 225

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(204)
Mit Volltextzugriff
(177)

Publikationsform

Artikel
(224)
Buchkapitel
(1)

Sprache

Englisch
(224)
Deutsch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(106)
Life Sciences & Biomedicine
(93)
Humans
(68)
Male
(36)
Female
(33)
Biological And Medical Sciences
(31)
Animals
(28)
Medical Sciences
(25)
Adult
(20)
Middle Aged
(20)
Aged
(18)
Surgery
(13)
Internal Medicine
(12)
Technology
(11)
Cardiovascular System & Cardiology
(10)
Infectious Diseases
(10)
Public, Environmental & Occupational Health
(10)
Cardiac & Cardiovascular Systems
(9)
Dogs
(9)
Microbiology
(9)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

P16 Generalized Prevalence-Adjusted Willingness-to-Pay to Control for Health Equity in Cost-Effectiveness Analysis

Comparing tyrosine kinase inhibitor treatment strategies for newly diagnosed chronic myeloid leukemia in chronic phase when imatinib loses patent exclusivity in the u.s.: a cost-effectiveness analysis

Are evidence-based practices associated with effective prevention of hospital-acquired pressure ulcers in u.s. Hospitals?

HSD56 Utilization of Vascular Assessment Before Lower Extremity Amputation Among Patients With Diabetic Foot Ulcerations in the US

Determining the cost of obesity and its common comorbidities from a commercial claims database

EE35 Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Vs. Pembrolizumab Plus Chemotherapy for the First-Line Treatment of Non-Squamous, Advanced Non-Small Cell Lung Cancer in the USA

P18 Assessing the Value of Revascularization Strategies for Chronic Limb Threatening Ischemia in Patients with Diabetic Foot Ulcers: A Propensity Score-Weighted Evaluation

HPR4 $20.9 Billion Annually Wasted on “Defects in Value” for Total Knee and Hip Replacements in the United States

HSD90 Value as the Next Innovation in Rectal Cancer Surgery: A Review

EE419 Cost-Effectiveness Analysis of Non-Invasive Screening in Patients with Diabetic Foot Ulcers

EE395 Cost-Effectiveness of Respiratory Syncytial Virus Prophylaxis in Preterm Infants 29-35 Weeks' Gestation

EE288 A Cost-Effectiveness Analysis of Biologic Compared with Chemical Disease Modifying Drugs in Treating Multiple Sclerosis in US

EE245 Cost-Effectiveness of Therapeutic Hypothermia for Neonates with Mild Hypoxic-Ischemic Encephalopathy

PIH10 A Cost-Effectiveness Analysis of Repositioning Intervals for Pressure Injury Prevention: An Economic Evaluation of the "TEAM-up” Clinical Trial

EE209 Value Defects in Spine Surgery: How to Reduce Wasteful Care and Improve Value

EE342 Compression Therapy with Early Endovenous Ablation in Venous Leg Ulceration in the U.S.: A Cost-Effectiveness Analysis

PIH16 ESTIMATING THE VALUE OF NURSING TIME TO REDUCE COSTS AND INCREASE QUALITY OF PRESSURE INJURY PREVENTION IN NURSING HOMES: A COST-EFFECTIVENESS ANALYSIS OF THE TEAM-UP CLINICAL TRIAL

EE136 Cost-Effectiveness Analysis of Tisagenlecleucel Using Long-Term Survival Outcomes in Treating Adult Patients with Relapsed or Refractory Large B-Cell Lymphoma from US Societal Perspective

EE404 A Cost-Effectiveness Analysis of a Triple-Agent Topical Fixed-Dose Combination of 1.2% Clindamycin Phosphate, 0.15% Adapalene, and 3.1% Benzoyl Peroxide Gel for the Treatment of Moderate-to-Severe Acne Vulgaris in the United States

PIN21 The Cost-Utility of Remote Pulse-Oximeter Monitoring of COVID19 Patients

PIN150 Economic VALUE of Treatment and Vaccine Technologies to Address the COVID-19 Pandemic: A Cost-Effectiveness and Budget IMPACT Analysis

PMU39 COOKING AT HOME CAN SAVE MONEY, REGARDLESS OF FOOD PRICE: A MULTILEVEL ANALYSIS OF MEALS PREPARED AWAY FROM THE HOME ON DIET MEASURES AND FOOD EXPENDITURES

PMU58 SMART SPENDING: REALLOCATING AMERICANSâ€™ FOOD BUDGETS TO SAVE COSTS AND IMPROVE DIET QUALITY

PCN67 USING INFORMATION FROM THE MICROBIOME TO IMPROVE THE EFFICIENCY OF SELECTING THERAPEUTIC OPTIONS FOR MELANOMA: A COST-EFFECTIVENESS ANALYSIS

What is the Most Cost-Effective Strategy for Treating Chronic Myeloid Leukemia After Imatinib Loses Patent Exclusivity in Europe?

Suchergebnisse filtern